Buchumschlag

Calorie labeling laws: who is affected and why?

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Charles Courtemanche
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Obesity
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
von: Sheila Pintado-Cucarella
Veröffentlicht: (2016)

Effect of Calorie Restricted Diet Versus Liraglutide on Intrapancreatic Fat Deposition in People With Obesity: A Pilot Study
von: Haiyan Cheng, et al.
Veröffentlicht: (2026)

The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD
von: Yasmina Chouik, et al.
Veröffentlicht: (2024)

Time‐restricted eating affects human adipose tissue fat mobilization
von: Carolina Zambrano, et al.
Veröffentlicht: (2024)

An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy
von: Anna Zenno, et al.
Veröffentlicht: (2024)

Planning laws as part of a systems approach are needed to improve children's health and reduce inequalities
von: Shu Wen Ng, et al.
Veröffentlicht: (2024)

Age of obesity onset affects subcutaneous adipose tissue cellularity differently in the abdominal and femoral region
von: Jessica Murphy, et al.
Veröffentlicht: (2024)

A systematic review of the effectiveness of attentional bias modification to support weight management in individuals who are overweight or obese
von: Catherine Heidi Seage
Veröffentlicht: (2024)

Does deciding not to participate in a lifestyle intervention for children with obesity affect the long‐term weight change?
von: Rasmus M. Jørgensen, et al.
Veröffentlicht: (2025)

Food and alcohol disturbance among people who have undergone bariatric surgery
von: Gretchen E. White, et al.
Veröffentlicht: (2024)

Validity of dietary assessment methods compared with doubly labeled water in children: A systematic review and meta‐analysis
von: Sanaz Mehranfar, et al.
Veröffentlicht: (2024)

A ketogenic diet lowers myocardial fatty acid oxidation but does not affect oxygen consumption: a study in overweight humans
von: Thien Vinh Luong, et al.
Veröffentlicht: (2024)

Characterisation of real‐world patients who discontinued a glucagon‐like peptide‐1 agonist
von: Jessica Van Laren, et al.
Veröffentlicht: (2026)

Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery
von: Yi Tang, et al.
Veröffentlicht: (2024)

Enfoque de la obesidad infantil desde la pediatría
von: Erika F. Hurtado-López
Veröffentlicht: (2014)

The extent and predictors of off‐label use of GLP ‐1 receptor agonists for weight loss management
von: Zbigniew Siudak, et al.
Veröffentlicht: (2025)

Representation of adults with class III obesity in studies assessing validity of self‐reported energy intake using doubly labeled water: A systematic review
von: Erica M. Howes, et al.
Veröffentlicht: (2024)

Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial
von: Filip K. Knop, et al.
Veröffentlicht: (2026)

Early childhood executive control modulates negative affectivity's role in increasing adolescent body mass index trajectories
von: Cara C. Tomaso, et al.
Veröffentlicht: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
von: Iskandar Idris
Veröffentlicht: (2024)

An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I
von: Snezana Milanovic, et al.
Veröffentlicht: (2025)

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
von: Iskandar Idris
Veröffentlicht: (2024)

Adipose Tissue in SARS ‐ CoV ‐2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update
von: Liam Charles Maher, et al.
Veröffentlicht: (2025)

Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
von: Peter Novodvorský, et al.
Veröffentlicht: (2025)

Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
von: Line Davidsen, et al.
Veröffentlicht: (2025)

Real‐world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases
von: Tarita Murray‐Thomas, et al.
Veröffentlicht: (2025)

An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
von: Esther Latres, et al.
Veröffentlicht: (2025)

Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus‐affected pregnancy
von: Majken Lillholm Pico, et al.
Veröffentlicht: (2025)

Adipose Tissue Analysis Toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue
von: Jacob J. Robino, et al.
Veröffentlicht: (2024)

Impact of Genetic Predisposition to Obesity on Long‐Term Maintenance of Modest Weight Loss in Postmenopausal Women
von: Harold H. Lee, et al.
Veröffentlicht: (2026)

Behavior reallocations within 24‐h movement profiles and change in cardiometabolic biomarkers during pregnancy
von: Sylvia E. Badon, et al.
Veröffentlicht: (2024)

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study
von: Yuta Nakamura, et al.
Veröffentlicht: (2024)

Oppositely biased glucagon‐like peptide‐1 receptor agonism does not differentially affect lipid metabolism in APOE *3‐Leiden CETP mice
von: Melanie Modder, et al.
Veröffentlicht: (2025)

A meta‐analysis and polygenic score study identifies novel genetic markers for waist‐hip ratio in African populations
von: Michael Zhong, et al.
Veröffentlicht: (2024)

Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial
von: Congqing Pan, et al.
Veröffentlicht: (2025)

Greater intrinsic motivation for engaging in healthy lifestyle behaviors is associated with reduced postpartum weight
von: Susan D. Brown, et al.
Veröffentlicht: (2025)

The association of higher offspring early‐childhood weight gain with prepregnancy metabolic and bariatric surgery
von: Maya‐Jean Hilaire, et al.
Veröffentlicht: (2024)

Dapagliflozin‐Associated Reduction in Liver Fat Is Independent of Weight Loss in Patients With Type 2 Diabetes
von: Anna V. Naumova, et al.
Veröffentlicht: (2026)

Low‐calorie diet‐induced weight loss is associated with altered brain connectivity and food desire in obesity
von: Hai Hoang, et al.
Veröffentlicht: (2024)

BALLAST study: A multicentre, open‐label, randomized‐controlled, 52‐week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine‐enriched amino acid supplementation and physical exercise programme
von: Yoshihiro Takahashi, et al.
Veröffentlicht: (2026)